A comparison of newborn versus old skin fibroblasts, their potential for tissue repair

Reference

1. • Cederholm-Williams S.A.
   • Houbrook S.
   • Porter N.W.
   • Marshall J.M.
   • Chissic H.
   Characterization of plasminogen activators secreted by human malignant cells.
   in: Hellman K. Eccles S.A. Treatment of metastasis, problems and prospects. Taylor & Francis, London1985: 347
   • Google Scholar
2. • Crutchley D.J.
   • Conannan L.B.
   • Maynard J.R.
   Human fibroblasts produce inhibitor directed against plasminogen activator when treated with glucocorticoids.
   Annals New York Academy of Sciences. 1981; 370: 609
   • Google Scholar
3. • Diamond L.
   • O'Brien T.G.
   • Baird W.M.
   Tumor promoters and the mechanism of tumor promotion.
   in: Klein G. Weinhouse S. Advances in Cancer Research. Academic Press, New York1980: 32
   • Google Scholar
4. • Diamond L.
   • O'Brien T.G.
   • Baird W.M.
   Tumor promoters and the mechanism of tumor promotion.
   in: Klein G. Weinhouse S. Advances in Cancer Research. Academic Press, New York1980: 1
   • Google Scholar
5. • Eaton D.L.
   • Baker J.B.
   Phorbol ester and mitogen stimulate human fibroblast secretion of plasmin-activatable plasminogen activator and protease nexin, an antiactivator/antiplasmin.
   Journal of Cell Biology. 1983; 97: 323
   • Google Scholar
6. • Hebert C.A.
   • Baker J.B.
   Linkage of extracellular plasminogen activator to the fibroblast cytoskeleton colocalization of cell surface urokinase with vinculin.
   Journal of Cell Biology. 1988; 106: 1241
   • Google Scholar
7. • Horiuchi Y.
   • Marshall J.M.
   • Masuzawa M.
   • Ryan T.J.
   • Cederholm-Williams S.A.
   Observations on fibroblast plasminogen activator inhibitor.
   in: Gaffney P.J. Castellino F.J. Plow E.F. Takada A. Fibrinolysis. John Libbey, London1986: 126 (suppl 1)
   • Google Scholar
8. • Kruithof E.K.O.
   Plasminogen activator inhibitors-A review.
   Enzyme. 1988; 40: 113
   • Google Scholar
9. • Masuzawa M.
   • Ryan T.J.
   Proteolysis and cell behaviour under the influence of physical force (abstract).
   International Journal of Microcirculation: Clinical and Experimental. 1985; 4: 297
   • Google Scholar
10. • Masuzawa M.
    • Hamazaki H.
    • Nishioka K.
    • Nishiyama S.
    • Ryan T.J.
    Urokinase-inhibitor of human skin fibroblasts-correlation with cell growth.
    in: Gaffney P.J. Castellino F.J. Plow E.F. Takada A. Fibrinolysis: current prospects. John Libbey, London, Paris1988: 119
    • Google Scholar
11. • Nishizuka Y.
    The role of protein kinase C in cell surface signal transduction and tumour promotion.
    Nature. 1984; 308: 693
    • Google Scholar
12. • Ryan T.J.
    Biochemical consequences of mechanical forces generated by distention and distortion.
    Journal of the American Academy of Dermatology. 1989; 21: 115
    • Google Scholar
13. • Siebert J.W.
    • Burd D.A.
    • McCarthy J.G.
    • Weinzweig J.
    • Ehrlich H.P.
    Fetal wound healing: a biochemical study of scarless healing.
    Plastic and Reconstructive Surgery. 1990; 85: 495
    • Google Scholar
14. • Strickland S.
    • Reich E.
    • Sherman M.I.
    Plasminogen activator in early embryogenesis: Enzyme production by trophoblast and parietal endoderm.
    Cell. 1976; 9: 231
    • Google Scholar
15. • Wigler M.
    • Weinstein I.B.
    Tumour promoter induces plasminogen activator.
    Nature. 1976; 259: 232
    • Google Scholar